About company
MirImmune is a biopharmaceutical company focused on the development of new and improved immunotherapies for cancer. Aiming to achieve long-term survival of cancer patients, MirImmune combine two leading approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies.
- US
- info@mirimmunebio.com
- Unknown
- mirimmunebio.com/
- Not verified company
